Results 141 to 150 of about 39,777 (194)

Routine immunization uptake and timeliness in young children exposed to multidrug-resistant tuberculosis: A secondary analysis of the Tuberculosis Child Multidrug-Resistant Preventive Therapy multi-site randomised controlled trial. [PDF]

BMC Glob Public Health
Patel F, Purchase S, Dhar M, Horne E, Grab J, Soma-Kasiram H, Sabet N, Martinson N, Staples S, Brigden J, Wilkinson T, Schaaf HS, Seddon J, Fairlie L, Hesseling A, Duong T.   +15 more
europepmc   +1 more source

Effect of Drug Cost-Exemption Policy on Treatment Outcomes in Multidrug-Resistant Tuberculosis Patients in Guangxi Zhuang Autonomous Region, China: A Nested Case-Control Study. [PDF]

Clinicoecon Outcomes Res
Liu A, Liao Y, Ye J, Wang Q, Huang J, Tang Y, Feng L.   +6 more
europepmc   +1 more source

From Repurposing to Refinement: Optimizing Levofloxacin for Treatment of Multidrug-Resistant Tuberculosis. [PDF]

Am J Respir Crit Care Med
Yim JJ.
europepmc   +1 more source

Predictive Factors Associated With Multidrug-Resistant Tuberculosis Among Tuberculosis Patients in Southwest Ethiopia: An Unmatched Case-Control Study. [PDF]

Health Sci Rep
Goshiye SM, Dube L, Mogas SB, Marine BT.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Multidrug-resistant tuberculosis

Clinica Chimica Acta
One of predominant contributors to global mortality is tuberculosis (TB), an infection caused by Mycobacterium tuberculosis (MTB). Inappropriate and ineffectual treatment can lead to the development of drug-resistant TB. One of the most common forms of drug-resistant TB is multidrug-resistant tuberculosis (MDR-TB), caused by mutations in the rpoB and ...
Dika Apriliana, Wulandari, Yeni Wahyuni, Hartati, Abdullahi Umar, Ibrahim, Dian Ayu Eka, Pitaloka, , Irkham   +4 more
openaire   +4 more sources

Management of Multidrug-Resistant Tuberculosis

Seminars in Respiratory and Critical Care Medicine, 2013
AbstractDrug-resistant strains of Mycobacterium tuberculosis pose a major threat to global tuberculosis control. Despite the availability of curative antituberculosis therapy for nearly half a century, inappropriate and inadequate treatment of tuberculosis, as well as unchecked transmission of M.
Charles L, Daley, Jose A, Caminero
openaire   +3 more sources

Multidrug resistance in Mycobacterium tuberculosis

International Journal of Antimicrobial Agents, 1997
All but one of the four major mechanisms of resistance to antimicrobial agents-inactivation of the drug, altered cell wall permeability or drug efflux, drug titration due to target overproduction, and alteration of the target by mutation-appear to be employed by Mycobacterium tuberculosis in its resistance to components of short course chemotherapy ...
Heym, B, Cole, S T
openaire   +3 more sources

Treatment of Multidrug-Resistant Tuberculosis

New England Journal of Medicine, 1993
The frequency of infections with M. tuberculosis resistant to antituberculous drugs is increasing in the United States and globally. This increase is a major threat to tuberculosis treatment and control programs. To prevent this situation from worsening, initial treatment programs that entail directly observed therapy supported by effective inducements
Alastair J.J. Wood, Michael D. Iseman
openaire   +2 more sources